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Background: The anticipation of mental health-related discrimination is common amongst people with mental
health problems and can have serious adverse effects. This study aimed to develop and validate a measure
assessing the extent to which people with mental health problems anticipate that they will personally experience
discrimination across a range of contexts.
Methods: The items and format for the Questionnaire on Anticipated Discrimination (QUAD) were developed from
previous versions of the Discrimination and Stigma Scale (DISC), focus groups and cognitive debriefing interviews
which were used to further refine the content and format. The resulting provisional version of the QUAD was
completed by 117 service users in an online survey and reliability, validity, precision and acceptability were
assessed. A final version of the scale was agreed and analyses re-run using the online survey data and data from an
independent sample to report the psychometric properties of the finalised scale.
Results: The provisional version of the QUAD had 17 items, good internal consistency (alpha = 0.86) and adequate
convergent validity as supported by the significant positive correlations with the Stigma Scale (SS) (r = 0.40, p < 0.001)
and the Internalised Stigma of Mental Illness Scale (ISMI) (r = 0.40, p < 0.001). Three items were removed due to low
endorsements, high inter-correlation or conceptual concerns. The finalised 14 item QUAD had good internal
consistency (alpha = 0.86), good test re-test reliability (ρc = 0.81) and adequate convergent validity: correlations with
the ISMI (r = 0.45, p < 0.001) and with the SS (r = 0.39, p < 0.001). Reading ease scores indicated good acceptability for
general adult populations. Cross-replication in an independent sample further indicated good internal consistency
(alpha = 0.88), adequate convergent validity and revealed two factors summarised by institutions/services and
interpersonal/professional relationships.
Conclusions: The QUAD expanded upon previous versions of the DISC. It is a reliable, valid and acceptable measure
which can be used to identify key life areas in which people may personally anticipate discrimination, and an overall
tendency to anticipate discrimination. It may also be useful in planning interventions aimed at reducing the stigma of
mental illness.
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A classic definition of stigma provided by Goffman is
“an attribute that is deeply discrediting”. It is further
noted that this attribute reduces the individual “from a
whole and usual person to a tainted, discredited one”
p.3. [1]. This suggests a socially constructed nature of
stigma in which individuals may become devalued in a
particular social context. Goffman further noted that this
fear of becoming “discredited” can have major impacts
on people’s lives leading them to conceal the stigmatised
condition or avoid situations in which they might be
stigmatised [2]. In this case, the affected group are people
with mental health problems.
There are different aspects of stigma such as perceived
stigma, self stigma and experienced stigma and there are
many levels at which stigma may operate [3,4]. However,
the concept of anticipated discrimination does not
appear to be adequately covered by existing definitions
of stigma. This concept refers back to Goffman’s early
notion of the fear of becoming personally ‘discredited’
based on a stigmatising condition and the associated
negative consequences [1], but draws upon the more
contemporary concept of discrimination (unfair treatment).
The perceptions that people with mental health problems
have that they will be viewed negatively or treated unfairly
may result in avoidant behaviour in situations where stigma
and discrimination is anticipated [2,5]. Furthermore, the
expectation of such rejection refers to the anticipated
responses of others which may or may not be as a result of
an actual experience of discrimination [6,7].
Research suggests that anticipated stigma may be a
common experience for people with mental health problems.
In a German survey examining both anticipated and
experienced stigma, people with a diagnosis of schizophrenia
or depression reported high levels of anticipated stigmatisa-
tion in accessing employment roles. These were 69% and
81.5% respectively [8]. However, only a small proportion of
these individuals had experienced such stigmatisation, 19%
and 1.9% respectively.
In relation to the anticipation of unfair treatment, an
international study found that over a third of participants
reported anticipated discrimination when seeking
employment and close personal relationships having
no experience of such discrimination [6]. The same
study investigated the level of anticipated discrimination in
people with schizophrenia across 27 different countries and
employed the use of four items from the Discrimination
and Stigma Scale (DISC-10) to assess anticipated dis-
crimination. Due to anticipated discrimination, partici-
pants reported that they had stopped themselves from
applying for employment, training or education (64%) and
looking for close relationships (58%). Feeling the need to
conceal their diagnosis (72%) was also highly related to
their expectation of avoidance by others if they knewabout their diagnosis [9]. Furthermore, 47% of people with
major depressive disorder who anticipated discrimination
in finding or keeping a job and 45% in their intimate
relationships had not experienced discrimination [10].
The findings of these studies demonstrate that anticipated
discrimination is not only common amongst people with
schizophrenia or depression but more importantly that this
is not necessarily related to experienced discrimination.
These results emphasise the importance of differentiating
between anticipated and experienced stigmatisation as
separate constructs and the relevance of this process in
planning stigma reducing interventions [8]. It is not
only important to introduce measures which reduce
the discrimination experienced from others but also
the discrimination anticipated by the individuals themselves
[9]. It can be expected that by addressing anticipated
stigmatisation or discrimination as part of a public
health intervention to reduce stigma, the anticipation
of discrimination and its negative consequences may
decrease following or at the same time as a reduction
in public stigma [4]. Consequently, greater understanding
of the contexts in which people anticipate stigma and
discrimination is needed. However, there are no current
scales which focus specifically on measuring personally
anticipated stigma or discrimination of people with mental
health problems across a wide range of contexts.
The anticipated discrimination when seeing a psychiatrist
scale (ADSP) produced three distinct factors relating to
‘anticipated discrimination’, ‘anticipated job problems’ and
‘anticipated shame’ [11]. However, this scale was specifically
developed to assess anticipated discrimination associated
with help seeking for a mental health problem. There
are also several scales which include items similar to
anticipated discrimination including the perceived discrim-
ination and devaluation scale (PDD), the stigma scale (SS)
and the internalised stigma of mental illness scale. Items of
the PDD scale such as “Most young women would be
reluctant to date a man who has been hospitalized
for serious mental disorder” [12], refer to the anticipation
of most other people and lacks personal relevance [13].
Furthermore, perceived discrimination scales ask respon-
dents to report the extent to which they perceive ‘people
with mental illness’ would be discriminated against rather
than their perceptions of how likely it is that they them-
selves will be discriminated against. Three disclosure items
of the SS refer to anticipated discrimination in personally
relevant life areas (employers, friends and neighbourhood).
However, the remaining seven disclosure items of the
SS refer to the management of disclosure to avoid
discrimination in general contexts with items such as “I
am scared of how other people will react if they find out
about my mental health problems” and “I avoid telling
people about my mental health problems” [14]. The social
withdrawal subscale of the ISMI refers to efforts to avoid
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others (“I stay away from social situations in order to
protect my family or friends from embarrassment”) or
to avoid detection of symptoms. Other items refer to
avoidance in more general contexts such as “I avoid
getting close to people who don’t have mental illness
to avoid rejection” [15]. Whilst the aforementioned
scales contain items referring to anticipated discrimination,
they are limited to a small number of areas of life in
which people with mental health problems may personally
anticipate stigmatisation or discrimination.
The subsection of the DISC-10 employed in the
International Study of Discrimination and Stigma Outcomes
(INDIGO) assesses some aspects of anticipated dis-
crimination, including avoidant behavioural responses
in the context of work and close personal relationships as
well as a disclosure item [6]. However, again these items
are restricted to a small number of contexts and focus on
responses to anticipated discrimination rather than the
anticipation itself. This study drew upon the existing items
of the experienced discrimination subscale of the DISC-10
to develop a measure of anticipated discrimination
(Questionnaire on Anticipated Discrimination-QUAD)
which covers a broad range of contexts in which stigma
may be personally anticipated.Aims
To develop a scale to assess the extent to which people
with mental health problems anticipate personally
experiencing mental health-related discrimination across
various domains of life. A further aim of this study is to
establish the psychometric properties of this scale: the
Questionnaire on Anticipated Discrimination (QUAD).Method
Design
The design is a four-stage psychometric validation study.
Stage one involved the development of QUAD where
initial items were formulated based on previous versions
of the DISC followed by two focus groups to formulate
any further items and refine the measure. There were
also cognitive debriefing interviews to finalise the wording
and format of the provisional version of the QUAD.
Stage two was a cross-sectional online survey in
which respondents completed the provisional QUAD
and other measures. In this stage a subsample re-completed
the provisional QUAD online two weeks later to assess
test-retest reliability. In stage three the research group
considered the findings, excluded some items and re-ran
the analyses in order to finalise the QUAD. Finally, in
stage four the analyses were re-run to establish the
psychometric properties of the finalised QUAD in an
independent sample and to explore its factor structure.Sample and recruitment
The inclusion criteria for participants in stages one to three
of the study were: 1) in contact with secondary mental
health outpatient services currently or in past 12 months;
and 2) aged 18 years or older. The eligibility criteria
for participants in stage four of the study were: 1) aged
18 years or older; 2) a clinical diagnosis of Depression,
Bipolar disorder or Schizophrenia spectrum disorders;
3) self-defined Black, White or Mixed (either Black or White)
ethnicity; and 4) current treatment with a community mental
health team.
Participants in the focus groups and cognitive debriefing
interviews (stage one) were mental health service users
living in South East England invited through the Mental
Health Research Network (MHRN). Participants for the
main study (stages two and three) were recruited through
advertisements on the websites of two national mental
health charities (Rethink Mental Illness, Mental Health
Foundation) and an advertisement on a social network
page (Facebook) of a national anti-stigma campaign
(Time to Change). The target sample size for the online
survey was 100, which was the required number to perform
the analyses outlined as part of the psychometric validation
of QUAD. A sample size of 40 was sufficient to establish
that the test-retest reliability is at least 0.7, assuming that
the true level is 0.8 (where α = 0.05; β = 0.20; number of
replications = 2) [16]. Participants in stage four were from
the MIRIAD (Mental Illness-Related Investigations on
Discrimination) study (part of the SAPPHIRE Research
Programme on Stigma and Discrimination in Mental
Health - www.sapphire.iop.kcl.ac.uk [17]). This was a
cross-sectional study of 202 individuals using secondary
mental health services in South London. Following
approval from members of the community mental
health teams (n = 14), the caseloads were screened based
on the eligibility criteria and eligible service users were
sent a letter inviting them to contact the research team if
they were interested in taking part.
Procedure
The QUAD scale was developed using an iterative
process. In stage one an early version of QUAD was
developed following an examination of previous versions
of the DISC scale [6,18] and on further work by our
group examining areas of life where discrimination may be
personally experienced not covered in the DISC [19,20].
Two focus groups took place in order to obtain feedback
on the initial version of the QUAD and cognitive debriefing
interviews were conducted in order to understand the
mental process used when answering the questions and to
further refine item wording and format, if necessary. In the
focus groups participants were shown a PowerPoint
presentation about the intial version of the QUAD,
asked to give their overall opinions and to discuss the
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asked to consider the format including the draft response
options and whether they found any question particularly
upsetting or distressing. Cognitive debriefing interviews
involved the researcher going through the initial QUAD
with each individual service user and obtaining feedback
about the measure [21]. In each component of stage one,
participants were asked to provide socio-demographic
information including details about age, gender and
ethnicity as well as self-reported clinical data.
In stage two written informed consent was obtained
from the participants in the main study prior to the start
of the survey. They were required to complete the
provisional version of the QUAD along with other measures
included in the online survey. Items on participants’
socio-demographic and clinical characteristics were
also included. Those who volunteered to complete the
QUAD for a second time were sent a link two weeks
later to complete the measure in order to obtain test-retest
data. Each participant received a £10 voucher in return for
their time. The aim of the online survey was primarily to
further develop and validate the QUAD but was also used
to validate an additional unrelated scale in development
(Barriers to Access to Care Evaluation - BACE) [22].
The online survey data were analysed to assess the
psychometric properties of the provisional QUAD.
In the third stage of the development the research group
considered the psychometric and conceptual properties of
the provisional QUAD, excluded a small number of items
on the basis of these findings, and re-ran the analyses in
order to produce a finalised version of the QUAD.
In stage four the psychometric properties of the finalised
QUAD were re-established using data from the MIRIAD
study. Written informed consent was obtained and partici-
pants were interviewed over two sessions (range 1–4) by
Research Assistants. The MIRIAD interview schedule col-
lected demographic and clinical information and contained
a battery of measures on stigma and discrimination
including the finalised 14 item QUAD, DISC and
ISMI. Participants in this stage received £15 as a thank you
for their time. As a final step we carried out an exploratory
factor analysis using the online survey sample (stage two)
to undertake a preliminary replication of the factor
structure found in the larger independent sample.
Measures
The version of the Questionnaire on Anticipated
Discrimination Scale (QUAD) used in the online survey
is a self-completion measure containing 17 items addressing
areas of anticipated discrimination. Participants are asked
to rate whether they expect to be treated unfairly in various
areas of life if people know about their mental health
problem. Each item requires a response on a four-point
Likert scale ranging from 0 (strongly disagree) to 3(strongly agree) and includes items such as “If friends
know about my mental health problem they will treat me
unfairly”. A mean score is calculated by adding each item
score and dividing by the number of applicable, non-
missing items in addition to a count score of the number
of areas of life in which individuals expect anticipated
discrimination.
The Stigma Scale (SS) is a 28-item measure used to
assess the stigma of mental illness. The scale comprises of
three sub scores which include discrimination (12 items),
disclosure (11 items) and positive aspects of mental
illness (5 items) [14]. Each item requires a response
on a five-point Likert scale ranging from “strongly
agree” to “strongly disagree”. The scale has good internal
consistency (α = 0.87) and adequate test-retest reliability
(kappa range 0.49 – 0.71) [14].
The Internalised Stigma of Mental Illness Scale (ISMI)
is a 29-item measure that assesses experiences of interna-
lised stigma in mental health service users. The scale is
composed of five subscales which include alienation,
stereotype endorsement, perceived discrimination, social
withdrawal and stigma resistance. Items require a response
on a four-point Likert scale ranging from “strongly agree”
to “strongly disagree”. Strong internal consistency
(α = 0.87) and test-retest reliability (r = 0.92) have been
reported for the scale [15].
The Discrimination and Stigma Scale (DISC) is measure
of discrimination experienced based on having a mental
health problem. The DISC has a 4-point Likert scale
(not at all; a little; moderately; a lot) and assesses experi-
ences of discrimination across 21 life domains including
family, friends, dating or intimate relationships, housing
and employment. The scale has been found to have good
reliability, validity and acceptability [18].
Participants in the online study were also asked to rate
the QUAD on a scale from 1 (very poor) to 10 (very good)
and were given the opportunity to comment on the overall
scale and individual items.
Analysis
Data were analysed using SPSS v15 and STATA v10.
The psychometric properties of the provisional and
final versions of the QUAD were established by assessing
the reliability, validity, precision and acceptability of the
measure.
Reliability
The internal consistency of the QUAD was assessed
using Cronbach’s alpha with a criterion of 0.70 taken as
indicating good internal consistency [23]. In order to
assess test-retest reliability of individual items, weighted
kappa coefficients were calculated with values above 0.40
indicating moderate agreement [24,25]. Lin’s concordance
was used to calculate the overall test-retest reliability for
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criterion of Lin’s ρc ≥0.70 was used to indicate acceptable
reliability [26].
Validity
Construct validity was established by assessing convergent
validity where it was anticipated that there would be
significant moderate positive correlations between the
QUAD, the Stigma Scale, the ISMI and the DISC. The
criterion for acceptable convergent validity was indicated
by correlation coefficient values between 0.40 and 0.70
[27]. In stage four construct validity was further assessed
by conducting an exploratory factor analysis. A subject to
item ratio of 10:1 was taken as an adequate sample size
for conducting factor analysis [28,29]. The 14 items were
analysed based on principal axis factoring with oblique
(promax) rotations as it was considered that the factors
would be correlated. The problems with retaining factors
with eigen values greater than one have been noted and
there is consensus in the literature that this is among the
least accurate methods [30-32]. The scree test has been
recommended as a better alternative, therefore the scree
plot was examined to identify the natural break point in
the data as an indicator of the number of factors to be
retained [31]. Items with factor loadings > 0.3 was taken as
the criteria for acceptable validity [33].
Precision
This refers to how well each item fits within the proposed
scale and the appropriateness of the scaling assumptions.
Corrected item-total correlations were examined where a
correlation < 0.30 was indicative of unacceptable fit of the
items with the total score of the scale [34].
Acceptability
In order to establish the extent to which the scale was
acceptable for its intended population the following
forms of acceptability were examined: 1) maximum
endorsement frequencies (MEF), 2) aggregate adjacent
endorsement frequencies (AEF), 3) Flesch reading ease
score and 4) respondent opinion. In considering MEF, the
N (%) of respondents endorsing each response category
was established. MEF >80% in any category indicates that
the item may need further consideration [35]. In addition,
a violation of the MEF criterion at either the top or
bottom end of the scale may indicate ceiling and floor effects
respectively. AEF assesses the proportion of responses in two
or more adjacent scale points of an item, where the criterion
of >10% was considered acceptable [35].
The Flesch reading ease score and the Flesch-Kincaid
Grade level functions in Microsoft Word were calcu-
lated in order to establish whether the wording of the
scale was suitable for the target audience. Reading ease
scores range from 0–100 with scores of 60–70 indicatingacceptability for general adult populations. Grade level
scores indicated the US educational grade to which the
document is most appropriate [36]. In order to assess the
level of participant burden, participants in the online
study were asked to rate their level of satisfaction
with the QUAD on a scale from 1 (very poor) to 10
(very good) and given the option to provide further
opinions on the scale.
Ethics
The QUAD study protocol was approved by the
King’s College London Psychiatry, Nursing and Midwifery
Research Ethics Sub-Committee (ref: PNM/09/10-103).
The MIRIAD study was approved by the East of England/
Essex 2 Research Ethics Committee (ref 11/EE/0052).
Results
Participants
Twenty five individuals participated in stage one: twenty
people took part in the service user focus groups and five
participated in the cognitive debriefing interviews. The
mean age of participants was 54 years old (sd = 12.69),
with an age range of 32 to 75 years. There were 13 female
(52%) and 11 male (44%) participants and the majority
(76%; n = 19) reported their ethnicity as White British,
Irish or any other White background. Four percent (n = 1)
reported their ethnicity as Black Caribbean, 12% (n = 3)
Indian or any other Asian background and 8% (n = 2)
as mixed ethnicity. Bipolar disorder (24%; n = 6) and
schizophrenia/schizo-affective disorders (20%; n = 5) were
the most commonly self–reported diagnoses.
One hundred and seventeen individuals completed the
online survey in stage two, and 59 of these participants
completed the QUAD at the second time point to provide
test-retest reliability data. There was no significant differ-
ence between the main sample and those providing test-
retest data in relation to age, gender, ethnicity, education,
employment status, age at first treatment, and hospital
admittance for psychiatric treatment. However, those with
non-psychotic conditions were more likely to be in the
retest sample (66% vs. 34%, Χ2 = 5.06, p = 0.02) compared
to those with psychotic conditions. The characteristics of
the participants in stages one and two are shown in Table 1.
The mean age of participants in stage two was 36 years,
with a range of 18 to 70 years. Eighty percent were female,
the majority reported their ethnicity as White British (87%),
and 42% were in full or part-time employment. Depression
(34%) and bipolar disorder (31%) were the most com-
mon self-reported primary diagnoses and 46% had been
hospitalised for a mental health problem.
Two hundred and two individuals took part in the
MIRIAD study (stage four). The demographic and clinical
characteristics of the participants in stage four are shown
in Table 2. The mean age of participants in stage four was
Table 1 Participants’ sociodemographic and clinical characteristics
Stage 1 participants
Variable N %
Gender (n = 24) Male 11 44.0
Female 13 52.0
Ethnicity (n = 25) White British 15 60.0
White Irish 2 8.0
Other white background 2 8.0
Black British/Black African 1 4.0
Indian/Bangladeshi 2 8.0
Other Asian background 1 4.0
Mixed 2 8.0
Age (n = 25) Mean (sd) = 54.24 (12.69) Range = 32 - 75
Self-reported diagnosis (if more than one, first listed) (n = 20) Schizophrenia/schizoaffective disorder 5 20.0
Bipolar disorder 6 24.0
Personality disorder 3 12.0
Depression 3 12.0
Obsessive compulsive disorder 2 8.0
Unipolar disorder 1 4.0
Stage 2 participants
Variable N %
Gender (n = 117) Male 24 20.5
Female 93 79.5
Ethnicity (n = 117) White British 102 87.2
White Irish 5 4.3
Other white background 5 4.3
Black British/Black African 2 1.8
Indian/Bangladeshi 2 1.8
White and Asian 1 0.9
Age (n = 115) Mean (sd) = 36.1(11.1) Range = 18 - 70
Highest level of education (n = 117) Higher education qualification/degree 61 54.7
Vocational qualification 16 13.7
A levels 17 14.5
GCSE/O level/CSE 19 16.2
No formal qualifications 1 0.9
Employment status (n = 117) Work full-time 33 28.2
Work part-time 16 13.7
Volunteer 19 16.2
Looking after own children 2 1.7
Student 11 9.4
Retired 1 0.9
Not working 35 30.0
Relationship status (n = 116) Single 52 44.8
Married/civil partnership/cohabiting 46 39.7
Divorced or separated 16 13.8
Widowed 2 1.7
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Table 1 Participants’ sociodemographic and clinical characteristics (Continued)
Any children (including adult and non-resident children) (n = 116) Yes 34 29.3
No 82 70.7
Self-reported diagnosis (if more than one, first listed) (n = 107) Schizophrenia/schizoaffective disorder 5 4.7
Bipolar disorder 33 30.8
Depression 36 33.6
Anxiety disorder 13 12.1
Personality disorder 17 15.9
Other 3 2.8
Ever admitted to hospital for psychiatric treatment? (n = 116) Yes 53 45.7
No 63 54.3
Any involuntary hospital admissions? (n = 114) Yes 12 10.5
No 102 87.2
Years since first treatment for mental health problem (n = 105) Mean(sd) = 23.03 (9.8) Range = 4 - 52
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as White, 38.1% as Black and 8.4% as Mixed. The majority
(47.5%) had a primary diagnosis of Schizophrenia
spectrum disorders, 32.2% had a diagnosis of Depression
and 20.3% had a diagnosis of Bipolar disorder.
Stage one: provisional version of the QUAD
Following the development and psychometric validation
of the DISC scale, there were recommendations to
develop a measure of anticipated discrimination [18].
The initial items of QUAD were based on the domains
in the DISC which measures personally experienced
discrimination. Items in the DISC such as ‘Have you been
treated unfairly in making or keeping friends?’ were
adapted to focus on the anticipation rather than the
experience of discrimination (‘If friends know about my
mental health problem they will treat me unfairly’). A total
number of 17 personal life domains (friends, neighbours,
dating/intimate relationships, housing officials, education,
spouse/partner, family, employers, work colleagues,
transport drivers and officials, religious community,
police, physical health staff, mental health staff [18],
benefit officials [6], parents of other children [19] and
children and teenagers in the street [20]) were adapted
and expanded from versions of the DISC scale and further
work by our research group to form the initial version of
QUAD.
The overall opinion of the participants in the focus
group was that the wording and format was good and
the domains were considered relevant. The media was
suggested as an important domain, however, this was
not considered to be a personal life area and therefore
not included. Participants also suggested the inclusion of
a ‘neither agree nor disagree’ category which was added
to the version later used in the cognitive - debriefing
interviews. Participants in the cognitive - debriefinginterviews found that the instructions were clear, that
the domains made sense hypothetically and were distin-
guishable. Furthermore, the ‘neither agree nor disagree’
category appeared to be overused during the cognitive-
debriefing interviews so was removed following this
stage. This was to avoid overuse of this category which
was a risk given that the anticipation of discrimination
refers to hypothetical situations.Stage two: psychometric properties of the provisional
version of the QUAD
Reliability
The Cronbach’s alpha value for the 17 item provisional
QUAD scale was 0.86 indicating good internal consistency.
All items were retained as when any of the items
were deleted, the alpha value remained above 0.8.
Eleven of the 17 items had kappa values between
0.61 and 0.80 indicating substantial agreement between
test and retest; one item (item 8 - If employers know
I have a mental health problem they will treat me
unfairly) had a value above 0.80 indicating almost
perfect agreement and the remaining five items had
values between 0.41 to 0.60 indicating moderate agree-
ment. Lin’s concordance for the provisional QUAD 17
items was ρc = 0.81 indicating substantial test-retest
reliability [37].Validity
The hypothesised significant moderate positive correlation
between the QUAD and the Stigma Scale was supported
(r = 0.40, p < 0.001). The QUAD was also significantly
correlated with the ISMI scale (r = 0.40, p < 0.001), indicating
a moderate positive correlation as hypothesised. Both
correlations were within the required threshold of 0.40 to
0.70 indicating adequate convergent validity.
Table 2 MIRIAD study participants’ socio-demographic and clinical characteristics
Variable Categories Total n = 202 Percentage
Gender Male 92 45.5
Female 110 54.5
Ethnicity expanded categories (self-defined) White British 92 45.5
White other 16 7.9
Mixed 17 8.4
Black British 24 11.9
Black African 28 13.9
Black Caribbean 25 12.4
Age (years) Mean (sd; range) 202 41.8 (11.1; 19–67)
Employment status Employed 46 22.8
Not employed 126 62.4
Student/Training/Volunteer 25 12.4
Missing 5 2.5
Education level No qualifications 25 12.4
Qualifications usually taken at age 16 50 24.8
A-levels/Vocational 67 33.2
Degree or higher 60 29.7
Relationship status Single 128 63.4
Married/Partner 45 22.3
Divorced/Widowed 29 14.4
Clinical diagnosis from case records Bipolar disorder 41 20.3
Depression 65 32.2
Schizophrenia 96 47.5
Psychiatric hospital admissions Ever admitted to hospital 139 68.8
Admitted in last 12 months 35 17.8
Compulsory admission in last 12 months 14 6.9
Mean (sd; range)
Years since first contact with mental health services 201 15.1 (11.1; 0–46)
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Corrected item-total correlations ranged from 0.26 to
0.66. One item (item 6 – ‘If a spouse or partner knows
about my mental health problem they will treat me
unfairly’) fell outside the criterion with a correlation
coefficient of < 0.30. However, inspection of Cronbach’s
alpha if this item was deleted did not increase the
overall reliability of the scale. The remaining 16
items satisfied the pre-specified criterion, indicating
acceptable fit of these items with the total score of
the scale.
Acceptability
Item 8 (‘If employers know I have a mental health
problem they will treat me unfairly’) was most highly
endorsed for the “strongly agree” response category at
52.7% and item 16 (‘If parents of children in my
neighbourhood know I have a mental health problemthey will treat me unfairly’) in the “agree” category at
53.9%. The MEF criterion was not violated as all response
categories contained < 80% of responses. In addition, there
was no violation of the MEF criterion at either the
top or bottom end of the scale indicating no ceiling
or floor effects. No items violated the AEF criterion
of < 10% when considering the adjacent categories of
“strongly agree” and “agree”, “agree” and “disagree”,
“disagree” and “strongly disagree”. All adjacent categories
contained > 10% of the responses on aggregate, indicating
good acceptability.
The Flesch Reading Ease score for the QUAD was 70.3
which was just above the level of 60–70, indicating that it
was slightly easier to read than documents intended for
the general adult population. The Flesch-Kincaid Grade
level was 7.3 indicating that it can be understood by
12–13 year olds. Respondents indicated positive opinions
of the scale with a mean rating of 7.26 on the 10-point
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was easy to complete.
Anticipated discrimination
The percentage of respondents reporting anticipated dis-
crimination for each of the 17 items is shown in Table 3.
The most highly reported areas of life in which people
anticipate discrimination were related to employers
(item 8) and children and teenagers in my community
(item 17), with 87.5% and 85.5% respectively endorsing
both the “strongly agree” and “agree” response categories.
These were followed by high levels of anticipated
discrimination from parents of children in my neighbour-
hood (81.7%), work colleagues (81.7%) and people in my
neighbourhood (78.4%). The least anticipated areas were
“If mental health staff (e.g. psychiatrist, psychiatric nurse,
social worker) know about my mental health problem
they will treat me unfairly” (item 15), with 26.7% and
“If a spouse or partner knows about my mental
health problem they will treat me unfairly” (item 6),
with 30.7%.
Stage three: finalisation of the QUAD
Following the psychometric evaluation of the 17 item
provisional QUAD, the research team consideredTable 3 Percentage of respondents reporting anticipated discrim
Item no. Statement
1. If friends know about my mental health problem they will t
2. If people in my neighbourhood know I have a mental healt
3. If a person I want to date or have an intimate relationships
problem they will treat me unfairly
4. If housing officials or landlords know I have a mental health
5. If teachers, lecturers or tutors know I have a mental health
6. If a spouse or partner knows about my mental health prob
7. If my family knows about my mental health problem they w
8. If employers know I have a mental health problem they wil
9. If work colleagues know I have a mental health problem th
10. If transport drivers and officials (e.g. bus driver, ticket inspec
health problem they will treat me unfairly
11. If benefit officials know I have a mental health problem the
12. If religious officials or the community (e.g. at church, mosqu
health problem they will treat me unfairly
13. If the police know I have a mental health problem they wil
14. If physical health staff (e.g. GP, nurse, dentist) know I have a
treat me unfairly
15. If mental health staff (e.g. psychiatrist, psychiatric nurse, soc
health problem they will treat me unfairly
16. If parents of children in my neighbourhood know I have a
17. If children and teenagers in my community know about m
% = strongly agree/agree response categories.
Note: Denominators less than n = 117 were due to missing data.these findings in order to finalise the QUAD. Item 6
(If a spouse or partner knows about my mental health
problem they will treat me unfairly) fell outside the
criterion of > 0.30 (r = 0.26). In addition, given the low
endorsement of this item about discrimination from a
partner/spouse (30.7%) and item 15 about discrimination
from mental health staff (26.7%) and a conceptual concern
that a spouse/partner and mental health staff would
usually or always know about an individual’s mental
health problem, these two items were deleted. The
team also noted that there were three items relating
to the neighbourhood: 1) people in my neighbourhood
(item 2), 2) parents of children (item 16), and 3) children
and teenagers (item 17). We considered that item 16 was
a sub-set of item 2, further, on examining the inter-item
correlation matrix found that this conceptual similarity
was reflected in a high correlation coefficient (r = 0.57).
Consequently item 16 was deleted.
Psychometric properties of the final version of the QUAD
Following the removal of three items from the provisional
version of the QUAD the analyses were re-run in order to
establish the reliability, validity, precision and acceptability
of the finalised 14 item QUAD. The Cronbach’s alpha
value for the finalised 14 item QUAD scale was 0.86ination for each item in the provisional version of the QUAD
% (n)
reat me unfairly 34.5 (40/116)
h problem they will treat me unfairly 78.4 (91/116)
with knows I have a mental health 65.5 (74/113)
problem they will treat me unfairly 73.9 (85/115)
problem they will treat me unfairly 46.1 (53/115)
lem they will treat me unfairly 30.7 (35/114)
ill treat me unfairly 49.6 (57/115)
l treat me unfairly 87.5 (98/112)
ey will treat me unfairly 81.7 (94/115)
tor, taxi driver) know about my mental 56.5 (65/115)
y will treat me unfairly 60.9 (70/115)
e or temple) know I have a mental 42.5 (48/113)
l treat me unfairly 63.8 (74/116)
mental health problem they will 43.2 (48/111)
ial worker) know about my mental 26.7 (31/116)
mental health problem they will treat me unfairly 81.7 (94/115)
y mental health problem they will treat me unfairly 85.5 (100/117)
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remained substantial with a Lin’s concordance of ρc = 0.81.
There was a significant moderate positive correlation
between the Stigma Scale and the 14 item version of
QUAD (r = 0.39, p < 0.001) and between the ISMI scale
and the QUAD (r = 0.45, p < 0.001). The correlation
coefficient between the ISMI and the QUAD was
within the required threshold of 0.40 to 0.70 [27] and
the coefficient between the Stigma Scale and the
QUAD was marginal and considered sufficiently near
the threshold to indicate adequate convergent validity.
In terms of precision, all items satisfied the pre-specified
criterion of > 0.30 indicating acceptable fit with the total
score of the 14 item scale. The acceptability of the scale
remained good with no violation of the MEF and AEF
criteria. The Flesch Reading Ease score was 69.1 indicating
good acceptability for general adult populations and
the Flesch-Kincaid Grade level was 8.2 indicating that it
can be understood by 13 to 14 year olds.
Stage four: cross-replication in an independent sample
The psychometric properties of the finalised QUAD
were further established using data from the MIRIAD
study. The Cronbach’s alpha value for the 14 item scale
used in the MIRIAD study was 0.88 indicating goodTable 4 Factor loadings from the exploratory factor analysis
QUAD items
11. If religious officials or the community (e.g. at church, mosque or temple)
know I have a mental health problem they will treat me unfairly
9. If transport drivers and officials (e.g. bus driver, ticket inspector, taxi driver)
know about my mental health problem they will treat me unfairly
10. If benefit officials know I have a mental health problem they will
treat me unfairly
13. If physical health staff (e.g. GP, nurse, dentist) know I have a mental
health problem they will treat me unfairly
12. If the police know I have a mental health problem they will treat me unf
4. If housing officials or landlords know I have a mental health problem
they will treat me unfairly
2. If people in my neighbourhood know I have a mental health problem
they will treat me unfairly
5. If teachers, lecturers or tutors know I have a mental health problem
they will treat me unfairly
7. If employers know I have a mental health problem they will treat me unfa
8. If work colleagues know I have a mental health problem they will
treat me unfairly
3. If a person I want to date or have an intimate relationships with knows
I have a mental health problem they will treat me unfairly
1. If friends know about my mental health problem they will treat me unfairl
14. If children and teenagers in the community know about my mental
health problem they will treat me unfairly
6. If my family knows about my mental health problem they will treat me un
Note: EFA using data from the MIRIAD study. Loadings < 0.3 are suppressed for inteinternal consistency. Convergent validity was assessed using
the ISMI and the DISC-12 scale. There was a significant
moderate positive correlation between the QUAD and the
ISMI scale (r = 0.46, p < 0.001) and between the QUAD and
the DISC scale (r = 0.45, p < 0.001). Both correlation
coefficients were within the required threshold of 0.40
to 0.70 indicating adequate convergent validity [27]. All
items satisfied the pre-specified criterion of > 0.30 for
precision, indicating acceptable fit of the 14 items. There
were also no violations of the MEF and AEF criteria.
We also conducted an exploratory factor analysis using
the MIRIAD study data (180 observations) to examine
the factor structure of the 14 item scale. A two factor
structure was yielded following inspection of the scree
plot with eigen values of 5.49 and 1.4 respectively. Factor
1 explained 35.08% of the variance and contained eight
items, all with factor loadings greater than 0.3 (Table 4).
These items appeared to refer to institutions/services.
Item 2 (people in my neighbourhood) loaded onto
this factor suggesting that the stigma or discrimination
anticipated within one’s community may be similar to that
of more organised institutions. Factor 2 explained 6.1% of
the variance and contained six items which appeared to
refer to interpersonal/professional relationships. All
except item 6 (family) had factor loadings greater than 0.3of the 14 item QUAD (MIRIAD sample)
















rpretation. Factor loadings for item 6 were < 0.3; both loadings are presented.
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criterion. This item also loaded onto factor 1 which may
indicate that the family can be seen as a form of institu-
tion. Although this item did not clearly load onto one fac-
tor it was retained as it is considered to be an
important life domain in which individuals anticipate
and experience mental health related discrimination
[10,38]. There was a moderate correlation (r = 0.56)
between the two factors and the two subscales
showed good internal consistency with alpha values of
0.84 and 0.73 respectively.
Replication of the factor analysis using the online
survey sample in stage two (91 observations) also yielded
a two factor structure with eigen values of 5.14 and 1.75
respectively. Factor 1 explained 32.64% of the variance
and contained eight items with factor loadings greater
than 0.3 (Table 5). Unlike the previous factor structure,
item 7 (employers) loaded onto the first factor whilst
item 2 (people in my neighbourhood) loaded onto the
second factor. However, the items on factor 1 may still
be considered to refer to institutions/services as employers
may also be viewed in this context. Factor 2 explained
8.7% of the variance and these six items may be seen
as referring to interpersonal/professional relationships as
‘people in my neighbourhood’ may also be viewed withinTable 5 Factor loadings from the exploratory factor analysis
QUAD items
10. If benefit officials know I have a mental health problem they will treat
me unfairly
13. If physical health staff (e.g. GP, nurse, dentist) know I have a mental
health problem they will treat me unfairly
5. If teachers, lecturers or tutors know I have a mental health problem they
will treat me unfairly
11. If religious officials or the community (e.g. at church, mosque or temple)
know I have a mental health problem they will treat me unfairly
4. If housing officials or landlords know I have a mental health problem they
will treat me unfairly
9. If transport drivers and officials (e.g. bus driver, ticket inspector, taxi driver)
know about my mental health problem they will treat me unfairly
12. If the police know I have a mental health problem they will treat me unf
7. If employers know I have a mental health problem they will treat me unfa
3. If a person I want to date or have an intimate relationships with knows
I have a mental health problem they will treat me unfairly
2. If people in my neighbourhood know I have a mental health problem the
will treat me unfairly
14. If children and teenagers in the community know about my mental
health problem they will treat me unfairly
8. If work colleagues know I have a mental health problem they will
treat me unfairly
1. If friends know about my mental health problem they will treat me unfairl
6. If my family knows about my mental health problem they will treat me un
Note: EFA using data from the online survey described in Stage 2. Loadings < 0.3 arthis context. There was a moderate correlation (r = 0.54)
between the two factors and the sub-scales showed good
internal consistency with alpha values of 0.82 and 0.76
respectively.
Discussion
This study presents findings on the development and
finalisation of a measure of the extent to which people
with mental health problems anticipate personally
experiencing mental health-related discrimination across
various life domains and its psychometric properties.
Prior to the development of the QUAD, there was no
existing measure addressing this vital concept [39], that
may have serious detrimental effects on people with
mental health problems. Consequently the QUAD is an
important addition to the portfolio of measures addressing
aspects of stigma and discrimination. The finalised 14
item QUAD was found to have good internal consistency,
test-retest reliability, adequate convergent validity and good
acceptability for general adult populations. Cross-replication
in an independent sample provided further evidence of its
reliability, acceptability and validity. The scale can be viewed
as consisting of two sub-scales summarised as anticipated
discrimination from institutions/services and anticipated
discrimination in interpersonal/professional relationships.of the 14 item QUAD (Initial sample in Stage 2)
















e suppressed for interpretation.
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ticipants anticipated discrimination were related to
‘children and teenagers in my community’, and ‘employers
and work colleagues’. Abuse by neighbourhood youth has
been noted in a recent overview of targeted violence and
harassment against people with mental health problems
[20]. The frequent reporting of anticipated discrimin-
ation from employers and work colleagues echoes the
finding that employment is an area in which individ-
uals have often stopped themselves from engaging in
due to the anticipation of unfair treatment [6,7], some-
times because of having experienced this [40]. This
may lead to decisional conflict at work, concealment of
mental health problems and the non-receipt of reasonable
adjustments [41-43].
Strengths and limitations
A major strength of this study is the multi-stage iterative
process used to develop the measure. Unlike other mea-
sures, the newly developed measure covers a wider range of
life contexts in which discrimination may be personally
anticipated as opposed to more general contexts. It is differ-
entiated from perceived discrimination scales in that it
assesses the extent to which people anticipate discri-
mination directed at themselves rather than at people with
mental health problems in general. Furthermore, the
QUAD is differentiated from the anticipated discrimination
section of the DISC in that the former assesses anticipation
itself whereas the latter focuses on responses to anticipa-
tion. A further strength is that the scale is both short and
simple to administer amongst its intended population as it
was designed as a self-completion measure which received
a positive overall rating by respondents. In addition, the
assessment of psychometric properties was comprehensive
in that it included concepts such as precision and maximum
endorsement frequencies. The psychometric properties were
also further established in an independent sample in order
to provide further information about the psychometric
properties of the scale.
A limitation of the study is that the sample for the
online survey was recruited through mental health-related
organisations, one being an anti-stigma campaign
(Time to Change) [44] and so may be atypical. These individ-
uals may be more likely to anticipate discrimination and may
be potentially engaged in efforts to reduce discrimination.
The online sample is also limited to those who have internet
access and the use of a computer. Males, individuals from
Black and minority ethnic groups and those with a
diagnosis of schizophrenia/schizoaffective disorders were
under-represented in this sample. However, the MIRIAD
sample overcomes these limitations as participants were
mental health service users engaging with community
mental health teams. The sample includes people with
psychosis and is more varied in terms of ethnicity andgender. The MIRIAD sample was also large enough to
conduct an exploratory factor analysis in order to provide
further information about the construct validity of the
QUAD items. In addition, although the sample in the
online survey was small in number and atypical, the ex-
ploratory factor analysis using this sample provides a
preliminary replication of the factor structure found in the
independent sample.
Application
The QUAD may be used to assess an individual’s level of
anticipated discrimination which is likely to be an
important addition in both research and clinical contexts.
We recommend general use of the total score as the
overall scale has demonstrated good reliability and
validity. Where the research question deems it appropriate,
subscales scores from the MIRIAD sample may also
be used. The QUAD can also be used to identify key life
domains in which people personally anticipate mental
health related discrimination which may highlight areas of
focus when developing anti-stigma initiatives. It may be
used as a complementary scale to measures of experienced
discrimination such as the Discrimination and Stigma Scale
(DISC-12) [10] as well as in conjunction with other
measures assessing the behavioural responses to both
anticipated and experienced discrimination such as the
Stigma Scale [14] and the Perceived Devaluation and
Discrimination Scale [12]. The 14 item QUAD is
available for use (see Additional file 1) together with
its manual and conditions of use from www.sapphire.
iop.kcl.ac.uk [17]. Queries should be addressed to the
corresponding and/or last author.
Implications for future research
Although the psychometric properties of the QUAD have
been established in an independent sample, additional
research would be beneficial in order to provide further
evidence of the validity of the scale. This includes further
replication of the exploratory factor analysis and a
confirmatory factor analysis in order to establish
whether the identified two factor structure from the
MIRIAD sample can be replicated. Further research is
also required to establish how the QUAD relates to
measures of experienced discrimination and internalised
stigma in order to further investigate the association
between the three concepts. Such research questions
are being addressed by our research group using data
from the MIRIAD study.
Conclusions
The QUAD is a newly developed measure which can be used
to assess levels of anticipated discrimination amongst people
with mental health problems and this study provides prelim-
inary evidence for its reliability, validity and acceptability.
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[6,18] and upon further work by our group examining areas
of life where discrimination may be personally experienced,
followed by focus groups and cognitive - debriefing inter-
views. The items were finalised following an online survey of
117 mental health service users, resulting in a comprehensive
measure of anticipated discrimination which covers a broad
range of contexts in which mental health discrimination may
be anticipated. The QUAD can be used to identify the key
life domains in which people personally anticipate
discrimination and may be useful in evaluating interventions
aimed at reducing the stigma of mental illness.
Additional files
Additional file 1: Questionnaire on anticipated discrimination.
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